Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net deposit increase | -6.00%53.82B | -30.68%45.02B | -5.24%52.09B | 21.16%57.52B | 13.74%57.25B | 21.06%64.95B | 49.53%54.96B | 4.76%47.47B | 34.91%50.34B | 48.76%53.65B |
| Net increase in borrowings from central bank | --518.25M | --1.2B | --1.82B | ---- | ---- | ---- | ---- | --6.99B | --1.56B | --799.49M |
| Cash received from interests, fees and commissions | -0.88%13.93B | 8.55%10.05B | 9.89%5.08B | 6.88%18.8B | 6.60%14.06B | 5.51%9.26B | 9.40%4.62B | 8.60%17.59B | 10.93%13.19B | 10.49%8.78B |
| Net increase in repurchase business capital | 111.70%3.45B | --2.27B | ---- | -68.19%3.06B | -80.33%1.63B | ---- | ---- | 140.36%9.61B | 16.80%8.29B | -56.63%3.61B |
| Net increase in funds disbursed | 86.28%11.75B | 286.13%9.25B | --4.95B | -36.48%7.29B | -5.01%6.31B | -74.22%2.4B | ---- | 45.99%11.48B | 209.87%6.64B | 129.70%9.29B |
| Cash received relating to other operating activities | -48.70%173.69M | -68.58%169.17M | -73.65%134.08M | 293.38%989.52M | -23.65%338.6M | 29.83%538.4M | 150.66%508.76M | -61.88%251.54M | -50.98%443.49M | -36.60%414.7M |
| Adjustment items of operating cash inflws | ---- | ---- | ---1.89B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 5.56%86.17B | -15.99%68.28B | 0.83%62.81B | -6.97%88.74B | 0.18%81.63B | 1.33%81.27B | 26.94%62.29B | 24.36%95.39B | 29.84%81.48B | 32.96%80.21B |
| Staff behalf paid | 2.47%2.26B | 4.49%1.71B | 2.86%1.13B | 2.27%2.8B | 2.49%2.21B | -0.06%1.64B | -3.54%1.1B | 17.09%2.73B | 15.91%2.15B | 18.65%1.64B |
| All taxes paid | -20.04%1.46B | -32.57%937.34M | -48.64%235.01M | 10.91%2.66B | -2.35%1.83B | -2.10%1.39B | 9.83%457.57M | 10.00%2.4B | 6.06%1.87B | 0.58%1.42B |
| Net loan and advance increase | 1.26%41.83B | 0.45%36.27B | 10.79%34.19B | -0.65%45.52B | 4.65%41.31B | 7.22%36.11B | 70.70%30.87B | 8.49%45.82B | 17.25%39.47B | 27.02%33.68B |
| Net deposit in central bank and institutions | -41.62%1.74B | -64.20%1B | -48.36%1.31B | 71.41%3.15B | 67.80%2.98B | 105.95%2.8B | 124.78%2.55B | 812.75%1.84B | 293.57%1.78B | 89.07%1.36B |
| Net lend capital | ---- | ---- | --2.33B | ---- | ---- | ---- | ---- | -18.54%8.94B | -85.37%1.5B | ---- |
| Cash paid for fees and commissions | 2.85%7.41B | 2.56%5.39B | 0.85%2.84B | 6.89%9.16B | 6.82%7.21B | 11.83%5.26B | 26.59%2.82B | 0.70%8.57B | -1.08%6.75B | -0.24%4.7B |
| Net increase in financial assets held for trading purposes | ---- | --4.23B | ---- | 54.24%6.9B | -84.39%437.18M | ---- | ---- | --4.47B | --2.8B | --4.12B |
| Net increase in resale business funds (operating) | ---- | --1.08B | --1.25B | --1.77B | ---- | ---- | ---- | ---- | ---- | --2.85B |
| Cash paid relating to other operating activities | 75.39%1.77B | 63.28%1.39B | -43.40%524.29M | 114.08%1.07B | 97.93%1.01B | 71.69%852.27M | 24.37%926.33M | -37.70%501.65M | -56.00%509.25M | -62.38%496.41M |
| Cash outflows from operating activities | 1.17%58.1B | 4.79%52.01B | 18.60%51.95B | -1.46%77.77B | 1.04%57.43B | -1.25%49.63B | 60.47%43.8B | 3.68%78.93B | -9.04%56.84B | 7.75%50.26B |
| Net cash flows from operating activities | 15.98%28.07B | -48.60%16.27B | -41.25%10.86B | -33.38%10.97B | -1.81%24.2B | 5.66%31.64B | -15.10%18.49B | 2,735.25%16.47B | 8,892.87%24.65B | 118.89%29.95B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 30.62%185.97B | 59.85%143.93B | 83.09%82.07B | 13.14%204.48B | 9.25%142.37B | -4.95%90.04B | 0.16%44.83B | -45.62%180.74B | -46.87%130.32B | -39.52%94.73B |
| Cash received from returns on investments | 6.44%5.44B | -28.71%2.72B | -29.09%1.45B | -3.72%5.71B | 8.64%5.11B | 10.44%3.82B | 39.93%2.05B | 1.30%5.93B | 5.59%4.7B | 15.20%3.46B |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 56.06%9.91M | 25.50%7.97M | --9.01M | 483.72%12.28M | 62.71%6.35M | 62.71%6.35M | ---- | -93.30%2.1M | --3.9M | --3.9M |
| Cash inflows from investing activities | 29.79%191.42B | 56.25%146.67B | 78.22%83.53B | 12.61%210.2B | 9.23%147.48B | -4.41%93.87B | 1.40%46.87B | -44.81%186.67B | -45.94%135.02B | -38.48%98.2B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 7.19%283.48M | -0.26%188.69M | 73.39%127.96M | 22.43%515.35M | -9.44%264.47M | -6.69%189.17M | -24.07%73.79M | 0.41%420.93M | 8.43%292.04M | 29.11%202.74M |
| Cash paid to acquire investments | 27.40%224.98B | 44.11%163.73B | 42.06%75.96B | 17.56%236.79B | 18.83%176.59B | -1.70%113.61B | -6.85%53.47B | -42.66%201.42B | -43.66%148.6B | -34.65%115.58B |
| Cash outflows from investing activities | 27.37%225.27B | 44.04%163.92B | 42.10%76.09B | 17.57%237.31B | 18.78%176.85B | -1.71%113.8B | -6.88%53.54B | -42.61%201.84B | -43.61%148.9B | -34.59%115.78B |
| Net cash flows from investing activities | -15.26%-33.85B | 13.44%-17.26B | 211.60%7.45B | -78.68%-27.1B | -111.67%-29.37B | -13.37%-19.94B | 40.84%-6.67B | -12.51%-15.17B | 2.87%-13.88B | -1.18%-17.58B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --1.35B | --351.49M | --609.03M | 9,438.46%6.3B | ---- | ---- | ---- | -43.88%66M | -43.88%66M | -43.88%66M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --66M | --66M | ---- | ---- | ---- | ---- | ---- | -43.88%66M | -43.88%66M | -43.88%66M |
| Cash from bonds issue | 6.21%168.7B | 26.49%104.24B | 64.09%52.82B | 24.19%243.6B | 7.28%158.83B | -6.62%82.41B | -29.69%32.19B | -12.38%196.15B | -14.94%148.05B | -25.12%88.26B |
| Cash received from the issuance of other equity instruments | ---- | ---- | ---- | 0.02%3B | ---- | ---- | ---- | 0.00%3B | 0.00%3B | 0.00%3B |
| Cash inflows from financing activities | 7.06%170.04B | 26.91%104.59B | 65.98%53.43B | 26.95%252.9B | 5.11%158.83B | -9.76%82.41B | -29.69%32.19B | -12.23%199.21B | -14.70%151.12B | -24.52%91.32B |
| Borrowing repayment | 3.96%158.21B | 10.89%102.82B | 85.87%70.2B | 15.16%231.42B | -6.71%152.19B | -11.62%92.72B | -36.67%37.77B | -4.66%200.96B | -0.93%163.14B | -9.70%104.91B |
| Dividend interest payment | -23.07%1.61B | -32.81%1.26B | 100.22%299.33M | 75.24%3.11B | 24.31%2.09B | 27.79%1.88B | -22.64%149.5M | -37.41%1.78B | -31.70%1.68B | -21.90%1.47B |
| -Including:Cash payments for dividends or profit to minority shareholders | 1.38%46.84M | 1.38%46.84M | ---- | 594.93%46.2M | 594.93%46.2M | 594.93%46.2M | ---- | -75.25%6.65M | -75.25%6.65M | -75.25%6.65M |
| Cash payments relating to other financing activities | --230.32M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of financing cash outflows | -9.33%91.55M | -4.35%65.37M | -9.92%33.16M | -1.04%138.95M | 4.01%100.97M | 6.49%68.35M | 5.31%36.81M | 4.34%140.4M | 0.46%97.07M | -6.55%64.18M |
| Cash outflows from financing activities | 3.73%160.14B | 10.01%104.15B | 85.84%70.54B | 15.67%234.67B | -6.39%154.38B | -11.06%94.67B | -36.60%37.96B | -5.09%202.88B | -1.38%164.92B | -9.89%106.45B |
| Net cash flows from financing activities | 122.39%9.9B | 103.62%443.25M | -196.70%-17.1B | 597.30%18.23B | 132.27%4.45B | 18.95%-12.26B | 59.07%-5.76B | -127.73%-3.67B | -238.91%-13.8B | -628.72%-15.12B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 63.78%-21.86M | -214.67%-16.59M | -70.95%3M | -12.38%66.16M | -168.20%-60.35M | -76.20%14.46M | 163.49%10.34M | -73.71%75.51M | -64.94%88.48M | -35.47%60.77M |
| Net increase in cash and cash equivalents | 630.16%4.1B | -5.24%-563.88M | -80.07%1.21B | 194.19%2.16B | 73.69%-773.98M | 80.16%-535.81M | 268.17%6.06B | -479.88%-2.29B | 23.06%-2.94B | -262.80%-2.7B |
| Add:Begin period cash and cash equivalents | 17.02%14.85B | 17.02%14.85B | 17.02%14.85B | -15.30%12.69B | -15.30%12.69B | -15.30%12.69B | -15.30%12.69B | 4.20%14.98B | 4.20%14.98B | 4.20%14.98B |
| End period cash equivalent | 59.06%18.95B | 17.53%14.28B | -14.37%16.05B | 17.02%14.85B | -1.04%11.91B | -1.04%12.15B | 64.82%18.75B | -15.30%12.69B | 14.07%12.04B | -9.92%12.28B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.